Expression of C‐kit in retinoblastoma: a potential therapeutic target

BACKGROUND: C‐kit is a transmembrane tyrosine kinase protein thought to play an important role in tumourigenesis. With the development of the compound imatinib mesylate, which specifically inhibits tyrosine kinase receptors, C‐kit has emerged as a potential therapeutic target. This study aims to det...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Barry, Robert J, de Moura, Letícia R, Marshall, Jean‐Claude, Fernandes, Bruno F, Orellana, Maria Eugenia, Antecka, Emilia, Martins, Claudia, Burnier, Miguel N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2007
Konular:
Laboratory Science - Scientific Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095433/
https://ncbi.nlm.nih.gov/pubmed/17591671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2007.119651
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller